ATI Physical Therapy (ATIP)
(Delayed Data from NYSE)
$5.74 USD
-0.17 (-2.86%)
Updated Sep 16, 2024 01:50 PM ET
After-Market: $5.91 +0.17 (2.94%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for ATI Physical Therapy, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 699 | 636 | 628 | 0 | 785 |
Cost Of Goods | 602 | 574 | 534 | 0 | 607 |
Gross Profit | 97 | 61 | 94 | 0 | 178 |
Selling & Adminstrative & Depr. & Amort Expenses | 124 | 601 | 1,074 | 2 | 119 |
Income After Depreciation & Amortization | -28 | -540 | -980 | -2 | 59 |
Non-Operating Income | 25 | 43 | 183 | 0 | -1 |
Interest Expense | 61 | 45 | 56 | 0 | 92 |
Pretax Income | -64 | -542 | -853 | -2 | -34 |
Income Taxes | 3 | -49 | -71 | 0 | -44 |
Minority Interest | 4 | -1 | -4 | 0 | 4 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -66 | -493 | -782 | -2 | 10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -70 | -492 | -778 | -2 | 5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 66 | 38 | 69 | -2 | 101 |
Depreciation & Amortization (Cash Flow) | 94 | 578 | 1,049 | 0 | 42 |
Income After Depreciation & Amortization | -28 | -540 | -980 | -2 | 59 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4.13 | 4.06 | 3.32 | NA | NA |
Diluted EPS Before Non-Recurring Items | -31.93 | -15.00 | -1.50 | NA | NA |
Diluted Net EPS (GAAP) | -31.93 | -125.50 | -234.50 | -2.00 | NA |
Fiscal Year end for ATI Physical Therapy, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 188.11 | 181.47 | 182.29 | 177.46 | 172.34 |
Cost Of Goods | 158.14 | 159.57 | 153.25 | 153.13 | 148.12 |
Gross Profit | 29.97 | 21.90 | 29.04 | 24.32 | 24.21 |
SG&A, R&D, and Dept/Amort Expenses | 23.34 | 26.68 | 32.07 | 25.09 | 36.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 6.63 | -4.78 | -3.03 | -0.77 | -12.36 |
Non-Operating Income | 5.71 | 5.60 | 15.75 | 1.76 | 7.38 |
Interest Expense | 14.90 | 14.48 | 14.94 | 15.48 | 16.68 |
Pretax Income | -2.57 | -13.66 | -2.22 | -14.48 | -21.66 |
Income Taxes | -0.01 | -0.13 | 2.29 | 0.13 | 0.09 |
Minority Interest | 1.18 | 1.13 | 1.12 | 0.59 | 0.96 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.55 | -13.52 | -4.51 | -14.61 | -21.75 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -3.74 | -14.65 | -5.62 | -15.20 | -22.71 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 4.35 | 4.18 | 4.16 | 4.15 | 4.12 |
Diluted EPS Before Non-Recurring Items | -2.43 | -4.61 | -2.15 | -4.42 | -15.80 |
Diluted Net EPS (GAAP) | -2.43 | -4.61 | -2.27 | -4.42 | -17.74 |